Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial

被引:1007
作者
Velikova, G
Booth, L
Smith, AB
Brown, PM
Lynch, P
Brown, JM
Selby, PJ
机构
[1] St James Univ Hosp, Canc Res UK, Clin Ctr Leeds, Canc Med Res Unit, Leeds LS9 7TF, W Yorkshire, England
[2] No & Yorkshire Clin Trials & Res Unit, Leeds, W Yorkshire, England
关键词
D O I
10.1200/JCO.2004.06.078
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To examine the effects on process of care and patient well-being, of the regular collection and use of health-related quality-of-life (HRQL) data-in oncology practice. Patients and Methods In a prospective study with repeated measures involving 28 oncologists, 286 cancer patients were randomly assigned to either the intervention group (regular completion of European Organization for Research and Treatment of Cancer-Core Quality of Life Questionnaire version 3.0, and Hospital Anxiety and Depression Scale on touch-screen, computers in clinic and feedback of results to physicians); attention-control group (completion of questionnaires, but no feedback); or control group (no HRQL measurement in clinic before encounters). Primary outcomes were patient HRQL over time, measured by the Functional Assessment of Cancer Therapy-General questionnaire, physician-patient communication, and clinical management, measured by content analysis of tape-recorded encounters. Analysis employed mixed-effects modeling and multiple regression. Results Patients in the intervention and attention-control groups had better HRQL than the control group (P = .006 and P = .01, respectively), but the intervention and attention-control groups were not significantly different (P = .80). A positive effect on emotional well-being was associated with feedback of data (P = .008), but not with instrument completion (P = .12). A larger proportion of intervention patients showed clinically meaningful improvement in HRQL. More frequent discussion of chronic nonspecific symptoms (P = .03) was found in the intervention group, without prolonging encounters. There was, no detectable effect on patient management (P = .60). In the intervention patients, HRQL improvement was associated with explicit use of HRQL data (P = .016), discussion of pain, and role function (P = .046). Conclusion Routine assessment of cancer patients' HRQL had an impact on physician-patient communication and resulted in benefits for some patients, who had better HRQL and emotional functioning. (C) 2004 by American Society of Clinical Oncology.
引用
收藏
页码:714 / 724
页数:11
相关论文
共 35 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
[Anonymous], 1999, Oncology (Williston Park), V13, P113
[3]  
Brown H, 1989, APPL MIXED MODELS ME
[4]   What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) study 5592 [J].
Cella, D ;
Eton, DT ;
Fairclough, DL ;
Bonomi, P ;
Heyes, AE ;
Silberman, C ;
Wolf, MK ;
Johnson, DH .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2002, 55 (03) :285-295
[5]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[6]  
Cohen J., 1988, STAT POWER ANAL BEHA
[7]  
Department of Health, 2000, NHS CANC PLAN
[8]   Health-related quality-of-life assessments and patient-physician communication - A randomized controlled trial [J].
Detmar, SB ;
Muller, MJ ;
Schornagel, JH ;
Wever, LDV ;
Aaronson, NK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (23) :3027-3034
[9]   Role of health-related quality of life in palliative chemotherapy treatment decisions [J].
Detmar, SB ;
Muller, MJ ;
Schornagel, JH ;
Wever, LDV ;
Aaronson, NK .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) :1056-1062
[10]   The lived experience of cardiac disease [J].
Margolis, Stephen A. .
AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (09) :645-645